Accountable care organizations have to work more on engaging physicians in meaningful leadership roles and should focus on learning about patient goals, said James Whitfill, MD, chief medical officer of Scottsdale Health Partners.
Accountable care organizations have to work more on engaging physicians in meaningful leadership roles and should focus on learning about patient goals, said James Whitfill, MD, chief medical officer of Scottsdale Health Partners.
Transcript (modified)
How can ACOs do a good job of engaging their physicians?
So physician engagement, while it’s something that everybody talks about, is actually pretty hard to do. A couple of things that we think that have been helpful for us in terms of achieving meaningful engagement is first having real physician leadership. So not just putting physicians in a place where they have a nominal voice, but in fact where they’re actually leading the organization.
At Scottsdale Health Partners, 90% of all our governance positions are filled by physicians. So they have a meaningful role in driving where the organization goes. And then I think making sure that they understand that this is a very different way of practicing, and this is a hard shift, it’s a hard shift for all of us to move from a fee-for-service world to a fee-for-value world.
So we do a lot of education, not just formal education but by physicians being in leadership roles they themselves have to learn, and sort of incorporate these new concepts of value-based healthcare.
How much do patients understand or know about the fact that they are in an ACO? And to they need to know?
So with our patients I don’t think we spend very much time talking about being in an ACO, but we spend a lot of time trying to figure out what their health goals are. Oftentimes, and this is surprising to us as physicians, patients are focused on their own goals, not my goals. And so if I don’t understand what their goals are, whether they are to be out of pain, or if they’re worried about their rent, or how they’re going to care for their children, those goals get in the way of them being able to focus on their health goals.
So we actually spend a lot time trying to understand what those barriers to care are, meeting the patients where they’re at, and then coming up with plans that first meet their goals and then we can mix in our health goals.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More